Indications
Chloroquine-resistant falciparum malaria
Treatment of all forms of malaria due to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae. The drug is also indicated for suppressive or prophylactic management, particularly in areas where resistance to chloroquine is known to exist.
Dosage And Administration
Curative treatment of malaria with a single dose-
Adults: 2-3 tablets
Children under 4 years: ½ tablets
4-8 years: 1 tablet
9-14 years: 2 tablets
In severe cases, Sulphadoxine & Pyrimethamine can be beneficially combined with quinine.
Suppressive or prophylactic management-
The dose given below should be taken at one time:
For semi-immune subjects (Dose: once every four weeks)-
Adults: 2-3 tablets
Children under 4 years: ½ tablets
4-8 years: 1 tablet
9-14 years: 2 tablets
For non-immune subjects (Dose: Once every two weeks)-
Adults: 2 tablets
Children under 4 years: 1½ tablets
4-8 years: 1 tablet
9-14 years: 1½ tablets
For malaria prophylaxis: The first dose of Sulphadoxine & Pyrimethamine should be taken one or two days before departure for an endemic area in order to protect tolerance, administration should be continued in the above dosage during the stay and also for four weeks after return or as prescribed by the physician.
Side Effects
Sulphadoxine & Pyrimethamine at the recommended dose is well tolerated. Main side effects are given below
Skin reactions: Drug rash, pruritus and slight hair loss have been observed.
Gastro-intestinal reactions: Feeling of fullness, nausea, rarely vomiting, stomatitis.
Haematological reactions: In rare cases, leukopenia, thrombocytopenia, and megaloblastic anemia have been observed.
Other reactions: Fatigue, headache, fever, polyneuritis may occasionally occur.
Precautions And Warnings
Impaired renal or hepatic function, folate deficiency, severe allergy or bronchial asthma, G6PD deficiency, pregnancy. Take with plenty of water to prevent crystalluria. Avoid excessive exposure to sun. Discontinue at the first sign of rash. Discontinue if signs of folic acid deficiency develops. Regular CBC monitoring, LFT, analysis of urine for crystalluria when admin for > 3 mth. Take with food to minimise Gi effects (e.g. anorexia and vomiting).
Pregnancy And Lactation
Sulphadoxine & Pyrimethamine is contraindicated during pregnancy, premature and newborn infants during the first weeks of life and intolerance to sulfonamide. If pregnancy can not be excluded, possible risks should be balanced against therapeutic effect. Both Pyrimethamine and Sulphadoxine are excreted in maternal breast milk. Nursing mother should not take this preparation.